Found 7 matching trials
Inflammation and Co-Infections in D²EFT PHASE4 i2-D²EFT substudy is an observational cohort nested within the parent D²EFT...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study to Determine Safety and Efficacy of Dolutegravir/Abacavir/Lamivudine (DTG/ABC/3TC) in Human Immunodeficiency Virus (HIV)-1 Infected Antiretroviral Therapy (ART) Naïve Women (ARIA) PHASE3 This study is designed to demonstrate the non-inferior antiviral activity o...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Dolutegravir Interactions With Artemisinin-based Combination Therapies PHASE1 Malaria and HIV are found in the same regions of the world and developing c...
Show More Location
Infectious Diseases Institute
Learn More & Join Trial
Dolutegravir and Darunavir Evaluation in Adults Failing Therapy PHASE4 D²EFT is a randomised, open-label study in HIV-1 infected patients failing ...
Show More Location
Hospital Dr Diego Paroissien
Learn More & Join Trial
Safety and Pharmacokinetics of Dolutegravir in Pregnant HIV Mothers and Their Neonates: A Pilot Study PHASE2 Aim: To evaluate dolutegravir (DTG) pharmacokinetics in pregnant HIV-infect...
Show More Location
Desmond Tutu HIV Foundation
Learn More & Join Trial
Improving HIV-1 Control in Africa with Long Acting Antiretrovirals PHASE3 IMPALA is a randomized, open-label, multicenter, interventional study of 54...
Show More Status
Active Not Recruiting
Location
Jaramogi Oginga Odinga Teaching & Referral Hospital
Learn More & Join Trial
Rapid Test and Treat Dolutegravir Plus Lamivudine Study in Newly Diagnosed Human Immunodeficiency Virus (HIV)-1 Infected Adults PHASE3 Early initiation of antiretroviral therapy (ART) reduces morbidity and mort...
Show More Location
GSK Investigational Site
Learn More & Join Trial